Secretaría de Gobernación
CONACYT
INGER
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17301
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorDOLORES MINO LEONes_MX
dc.creatorHORTENSIA REYES MORALESes_MX
dc.creatorSERGIO FLORES HERNANDEZes_MX
dc.date2015-
dc.date.accessioned2021-11-01T18:37:15Z-
dc.date.available2021-11-01T18:37:15Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17301-
dc.descriptionRationale, aims and objectives To evaluate the effectiveness of incorporating the pharmacist into the ambulatory health care team to increase the proportion of patients with type 2 diabetes mellitus (T2DM) and/or hypertension who adhere to their drug regimen and to improve disease control. Methods A non‐randomized clinical trial was carried out in patients with T2DM and/or hypertension from two primary care clinics. Patients from one of the clinics comprised the intervention group (IG) who received ‘counselling’ from the pharmacist. The control group (CG) was comprised of patients who attended another clinic and received the usual care. Adherence was measured by counting pills; hypertension control was evaluated by blood pressure and diabetes control by blood glucose. Statistical analysis was carried out by intention to treat using generalized linear models. Results There were 440 patients included. There was no difference in the proportion of IG and CG patients who adhered to treatment according to baseline measurements. An increase in the proportion of adherence at baseline and final determination was observed in both groups (IG 71–80%, P = 0.006 and CG 72–87%, P = 0.000). Generalized linear models showed a 55% or higher probability of IG patients achieving control of hypertension in comparison with the CG. Patients from the IG with T2DM have 13% more possibility of achieving glycaemic control than those of the CG. Conclusion Counselling offered by the pharmacist proved to be effective for improving drug adherence of diabetic and hypertensive patients in ambulatory health care.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherWileyes_MX
dc.relationhttps://onlinelibrary.wiley.com/doi/abs/10.1111/jep.12207es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceJournal of Evaluation in Clinical Practice (1365-2753) Vol. 21 (2015)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectDiabetes mellitus tipo 2es_MX
dc.subjectDiabetes mellitus, type 2es_MX
dc.subjectHipertensiónes_MX
dc.subjectHypertensiones_MX
dc.subjectTerapia medicinales_MX
dc.subjectDrug therapyes_MX
dc.titleEffectiveness of involving pharmacists in the process of ambulatory health care to improve drug treatment adherence and disease controles_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idMILD650803MDFNNL06es_MX
dc.creator.idREMH510406MDFYRR02es_MX
dc.creator.idFOHS571225HDFLRR00es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Journal of Evaluation in Clinical Practice (1365-2753) Vol. 21 (2015).pdf118.79 kBAdobe PDFVisualizar/Abrir